Feline lentiviruses demonstrate differences in receptor repertoire and envelope structural elements

Virology

Volumn 342, Issue 1, 2005, Pages 60-76

  Smirnova, Natalia ^a   Troyer, Jennifer L ^a   Schissler, Jennifer ^a   Terwee, Julie ^a   Poss, Mary ^b   VandeWoude, Sue ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

CXCR4; Envelope; Feline; Lentivirus; Receptor

Indexed keywords

ANTIBODY; CD134 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HEPARIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SUPERINFECTION; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATS; CELL LINE; DNA, VIRAL; GLYCOSYLATION; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUSES, FELINE; LIONS; MOLECULAR SEQUENCE DATA; PUMA; RECEPTORS, CXCR4; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, VIRUS; SEQUENCE HOMOLOGY, AMINO ACID; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRUS REPLICATION;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELINE LENTIVIRUSES; FELIS CATUS; LENTIVIRUS;

EID: 27444438322     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.07.024     Document Type: Article

References (129)

1. C.D. Ackley, J.K. Yamamoto, N. Levy, N.C. Pedersen, and M.D. Cooper Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus J. Virol. 64 11 1990 5652 5655
2. G. Alkhatib, C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 Science 272 5270 1996 1955 1958
3. J.S. Allan, B. Wilson, J. Potter, V. Hodara, L. Giavedoni, and R. White 22nd Annual Symposium on Nonhuman Primate Models for AIDS, San Antonio, TX 2004
4. R.W. Allison, and E.A. Hoover Feline immunodeficiency virus is concentrated in milk early in lactation AIDS Res. Hum. Retroviruses 19 3 2003 245 253
5. C. Apetrei, D.L. Robertson, and P.A. Marx The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa Front. Biosci. 9 2004 225 254
6. M.C. Barr, L. Zou, D.L. Holzschu, L. Phillips, F.W. Scott, J.W. Casey, and R.J. Avery Isolation of a highly cytopathic lentivirus from a nondomestic cat J. Virol. 69 11 1995 7371 7374
7. M.C. Barr, L. Zou, F. Long, W.A. Hoose, and R.J. Avery Proviral organization and sequence analysis of feline immunodeficiency virus isolated from a Pallas' cat Virology 228 1 1997 84 91
8. L.G. Barrientos, B.R. O'Keefe, M. Bray, A. Sanchez, A.M. Gronenborn, and M.R. Boyd Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus Antiviral Res. 58 1 2003 47 56
9. M. Bendinelli, M. Pistello, S. Lombardi, A. Poli, C. Garzelli, D. Matteucci, L. Ceccherini-Nelli, G. Malvaldi, and F. Tozzini Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen Clin. Microbiol. Rev. 8 1 1995 87 112
10. C.A. Bewley, and S. Otero-Quintero The potent anti-HIV protein cyanovirin-N contains two novel carbohydrate binding sites that selectively bind to Man (8) D1D3 and Man (9) with nanomolar affinity: implications for binding to the HIV envelope protein gp120 J. Am. Chem. Soc. 123 17 2001 3892 3902
11. R. Biek, A.G. Rodrigo, D. Holley, A. Drummond, C.R. Anderson Jr., H.A. Ross, and M. Poss Epidemiology, genetic diversity, and evolution of endemic feline immunodeficiency virus in a population of wild cougars J. Virol. 77 17 2003 9578 9589
12. A. Bjorndal, H. Deng, M. Jansson, J.R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D.R. Littman, and E.M. Fenyo Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype J. Virol. 71 10 1997 7478 7487
13. A.J. Bolmstedt, B.R. O'Keefe, S.R. Shenoy, J.B. McMahon, and M.R. Boyd Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner Mol. Pharmacol. 59 5 2001 949 954
14. A. Brelot, N. Heveker, K. Adema, M.J. Hosie, B. Willett, and M. Alizon Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses J. Virol. 73 4 1999 2576 2586
15. E.W. Brown, S. Miththapala, and S.J. O' Brien Prevalence of exposure to feline immunodeficiency virus in exotic Felid species J. Zoo Wildl. Med. 24 3 1993 357 364
16. E.W. Brown, N. Yuhki, C. Packer, and S.J. O'Brien A lion lentivirus related to feline immunodeficiency virus: epidemiologic and phylogenetic aspects J. Virol. 68 9 1994 5953 5968
17. M.J. Burkhard, L.A. Obert, L.L. O'Neil, L.J. Diehl, and E.A. Hoover Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus AIDS Res. Hum. Retroviruses 13 4 1997 347 355
18. S.M. Caney, M.J. Day, T.J. Gruffydd-Jones, C.R. Helps, T.R. Hirst, and C.R. Stokes Expression of chemokine receptors in the feline reproductive tract and large intestine J. Comp. Pathol. 126 4 2002 289 302
19. M.A. Carpenter, and S.J. O'Brien Coadaptation and immunodeficiency virus: lessons from the Felidae Curr. Opin. Genet. Dev. 5 6 1995 739 745
20. M.A. Carpenter, E.W. Brown, M. Culver, W.E. Johnson, J. Pecon-Slattery, D. Brousset, and S.J. O'Brien Genetic and phylogenetic divergence of feline immunodeficiency virus in the puma (Puma concolor) J. Virol. 70 10 1996 6682 6693
21. M.A. Carpenter, E.W. Brown, D.W. MacDonald, and S.J. O'Brien Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat Virology 251 2 1998 234 243
22. A. Carrillo, and L. Ratner Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants J. Virol. 70 2 1996 1301 1309
23. L.A. Chakrabarti The paradox of simian immunodeficiency virus infectino in sooty mangebys: active viral replication without disease progression Front. Biosci. 9 2004 521 539
24. Z. Chen, P. Zhou, D.D. Ho, N.R. Landau, and P.A. Marx Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry J. Virol. 71 4 1997 2705 2714
25. B. Chesebro, K. Wehrly, J. Nishio, and S. Perryman Mapping of independent V3 envelope determinants of human immunodeficiency virus type 1 macrophage tropism and syncytium formation in lymphocytes J. Virol. 70 12 1996 9055 9059
26. H. Choe, M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates Cell 85 7 1996 1135 1148
27. F. Corpet, J. Gouzy, and D. Kahn The ProDom database of protein domain families Nucleic Acids Res. 26 1 1998 323 326
28. A. de Parseval, and J.H. Elder Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor J. Virol. 75 10 2001 4528 4539
29. A. de Parseval, U. Chatterji, P. Sun, and J.H. Elder Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor Proc. Natl. Acad. Sci. U.S.A. 101 35 2004 13044 13049
30. A. de Parseval, S. Ngo, P. Sun, and J.H. Elder Factors that increase the effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication J. Virol. 78 17 2004 9132 9143
31. A. de Parseval, U. Chatterji, G. Morris, P. Sun, A.J. Olson, and J.H. Elder Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus Nat. Struct. Mol. Biol. 12 1 2005 60 66
32. S. de Rozieres, C.K. Mathiason, M.R. Rolston, U. Chatterji, E.A. Hoover, and J.H. Elder Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C J. Virol. 78 17 2004 8971 8982
33. H.K. Deng, R. Lui, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, and N.R. Landau Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661 666
34. B. Dey, D.L. Lerner, P. Lusso, M.R. Boyd, J.H. Elder, and E.A. Berger Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses J. Virol. 74 10 2000 4562 4569
35. L.J. Diehl, C.K. Mathiason-DuBard, L.L. O'Neil, and E.A. Hoover Plasma viral RNA load predicts disease progression in an accelerated feline immunodeficiency virus model J. Virol. 70 1996 2503 2507
36. G.A. Donzella, D. Schols, S.W. Lin, J.A. Este, K.A. Nagashima, P.J. Maddon, G.P. Allaway, T.P. Sakmar, G. Henson, E. De Clercq, and J.P. Moore AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor Nat. Med. 4 1 1998 72 77
37. B.J. Doranz, J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.B. Collman, and R.W. Doms A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors Cell 85 7 1996 1149 1158
38. T. Dragic, V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Nature 381 6584 1996 667 673
39. M.J. Dreitz, S.W. Dow, S.A. Fiscus, and E.A. Hoover Developmental of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus Am. J. Vet. Res. 56 1995 764 768
40. H.F. Egberink, E. De Clercq, A.L. Van Vliet, J. Balzarini, G.J. Bridger, G. Henson, M.C. Horzinek, and D. Schols Bicyclams, selective antagonists of the human chemokine receptor CXCR4, potently inhibit feline immunodeficiency virus replication J. Virol. 73 8 1999 6346 6352
41. J.H. Elder, G.A. Dean, E.A. Hoover, J.A. Hoxie, M.H. Malim, L. Mathes, J.C. Neil, T.W. North, E. Sparger, M.B. Tompkins, W.A. Tompkins, J. Yamamoto, N. Yuhki, N.C. Pedersen, and R.H. Miller Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1 AIDS Res. Hum. Retroviruses 14 9 1998 797 801
42. Y. Feng, C.C. Broder, P.E. Kennedy, and E.A. Berger HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 5263 1996 872 877
43. N.C. Gaddis, A.M. Sheehy, K.M. Ahmad, C.M. Swanson, K.N. Bishop, B.E. Beer, P.A. Marx, F. Gao, F. Bibollet-Ruche, B.H. Hahn, and M.H. Malim Further investigation of simian immunodeficiency virus Vif function in human cells J. Virol. 78 21 2004 12041 12046
44. R. Gupta, and S. Brunak Prediction of glycosylation across the human proteome and the correlation to protein function Pac. Symp. Biocomput. 2002 310 322
45. R. Gupta, L.J. Jensen, and S. Brunak Orphan protein function and its relation to glycosylation Ernst Schering Res. Found Workshop 38 2002 276 294
46. Gupta, R., Jung, E., Brunak, S., in preparation. Prediction of N-glycosylation Sites in 1085 Human Proteins.
47. H. Haining, E.L. McMonagle, E. Knapp, D. Klein, B.J. Willett, and M.J. Hosie 7th International Feline Retrovirus Research Symposium, Pisa, Italy 2004
48. W.D. Hardy Jr., A.J. McClelland, E.E. Zuckerman, H.W. Snyder Jr., E.G. MacEwen, D. Francis, and M. Essex Development of virus non-producer lymphosarcomas in pet cats exposed to FeLv Nature 288 5786 1980 90 92
49. D.R. Harper Virology LabFax 1st ed. B.D. Hames D. Rickwood The LabFax Series 1993 Academic Press London, UK
50. T. Hohdatsu, H. Hirabayashi, K. Motokawa, and H. Koyama Comparative study of the cell tropism of feline immunodeficiency virus isolates of subtypes A, B and D classified on the basis of the env gene V3-V5 sequence J. Gen. Virol. 77 Pt. 1 1996 93 100
51. M.J. Hosie, N. Broere, J. Hesselgesser, J.D. Turner, J.A. Hoxie, J.C. Neil, and B.J. Willett Modulation of feline immunodeficiency virus infection by stromal cell-derived factor J. Virol. 72 3 1998 2097 2104
52. M.J. Hosie, B.J. Willett, D. Klein, T.H. Dunsford, C. Cannon, M. Shimojima, J.C. Neil, and O. Jarrett Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence J. Virol. 76 12 2002 6062 6072
53. J. Ibrahim, P. Griffin, D.R. Coombe, C.C. Rider, and W. James Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes Virus Res. 60 2 1999 159 169
54. J. Johnston, and C. Power Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development J. Virol. 73 3 1999 2491 2498
55. J.B. Johnston, and C. Power Feline immunodeficiency virus xenoinfection: the role of chemokine receptors and envelope diversity J. Virol. 76 8 2002 3626 3636
56. J.B. Johnston, M.E. Olson, E.W. Rud, and C. Power Xenoinfection of nonhuman primates by feline immunodeficiency virus Curr. Biol. 11 14 2001 1109 1113
57. A. Joshi, T.W. Vahlenkamp, H. Garg, W.A. Tompkins, and M.B. Tompkins Preferential replication of FIV in activated CD4(+)CD25(+)T cells independent of cellular proliferation Virology 321 2 2004 307 322
58. K. Kato, H. Sato, and Y. Takebe Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism J. Virol. 73 7 1999 5520 5526
59. D. Klatzmann, E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.C. Gluckman, and L. Montagnier T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature 312 5996 1984 767 768
60. R.J. Langley, V.M. Hirsch, S.J. O'Brien, D. Adger-Johnson, R.M. Goeken, and R.A. Olmsted Nucleotide sequence analysis of puma lentivirus (PLV-14): genomic organization and relationship to other lentiviruses Virology 202 2 1994 853 864
61. D.L. Lerner, and J.H. Elder Expanded host cell tropism and cytopathic properties of feline immunodeficiency virus strain PPR subsequent to passage through interleukin-2-independent T cells J. Virol. 74 4 2000 1854 1863
62. J.A. Levy HIV and the Pathogenesis of AIDS 2nd ed. 1998 ASM Press Washington, DC
63. M.L. Linenberger, and T. Deng The effects of feline retroviruses on cytokine expression Vet. Immunol. Immunopathol. 72 3-4 1999 343 368
64. H.Y. Liu, Y. Soda, N. Shimizu, Y. Haraguchi, A. Jinno, Y. Takeuchi, and H. Hoshino CD4-dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses Virology 278 1 2000 276 288
65. S. Lombardi, C. Garzelli, M. Pistello, C. Massi, D. Matteucci, F. Baldinotti, G. Cammarota, L. da Prato, P. Bandecchi, and F. Tozzini A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity J. Virol. 68 12 1994 8374 8379
66. S. Lombardi, C. Massi, F. Tozzini, L. Zaccaro, A. Bazzichi, P. Bandecchi, C. La Rosa, M. Bendinelli, and C. Garzelli Epitope mapping of the V3 domain of feline immunodeficiency virus envelope glycoprotein by monoclonal antibodies J. Gen. Virol. 76 Pt. 8 1995 1893 1899
67. P.J. Maddon, A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss, and R. Axel The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain Cell 47 3 1986 333 348
68. R. Mariani, D. Chen, B. Schrofelbauer, F. Navarro, R. Konig, B. Bollman, C. Munk, H. Nymark-McMahon, and N.R. Landau Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif Cell 114 1 2003 21 31
69. K. Masuoka, T. Toyosaki, Y. Tohya, J. Norimine, C. Kai, and T. Mikami Monoclonal antibodies to feline lymphocyte membranes recognize the leukocyte-common antigen (CD45R) J. Vet. Med. Sci. 54 5 1992 865 870
70. R.A. McCaffrey, C. Saunders, M. Hensel, and L. Stamatatos N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies J. Virol. 78 7 2004 3279 3295
71. R.J. Miller, J.S. Cairns, S. Bridges, and N. Sarver Human immunodeficiency virus and AIDS: insights from animal lentiviruses J. Virol. 74 16 2000 7187 7195
72. T. Miyazawa, T. Furuya, S. Itagaki, Y. Tohya, E. Takahashi, and T. Mikami Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus Arch. Virol. 108 1-2 1989 131 135
73. T. Miyazawa, Y. Kawaguchi, T. Furuya, S. Itagaki, E. Takahashi, and T. Mikami Continuous production of feline immunodeficiency virus in a feline T-lymphoblastoid cell line (MYA-1 cells) Nippon Juigaku Zasshi 52 4 1990 887 890
74. T. Miyazawa, T. Toyosaki, K. Tomonaga, J. Norimine, K. Ohno, A. Hasegawa, C. Kai, and T. Mikami Further characterization of a feline T-lymphoblastoid cell line (MYA-1 cells) highly sensitive for feline immunodeficiency virus J. Vet. Med. Sci. 54 1 1992 173 175
75. T. Mori, and M.R. Boyd Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells Antimicrob. Agents Chemother. 45 3 2001 664 672
76. M.C. Muller, and F. Barre-Sinoussi SIVagm: genetic and biological features associated with replication Front. Biosci. 8 2003 D1170 D1185
77. A.A. Nabatov, G. Pollakis, T. Linnemann, A. Kliphius, M.I. Chalaby, and W.A. Paxton Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies J. Virol. 78 1 2004 524 530
78. R. Nielsen, and Z. Yang Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene Genetics 148 3 1998 929 936
79. Y. Nishimura, S. Nakamura, N. Goto, T. Hasegawa, H. Pang, Y. Goto, H. Kato, H.Y. Youn, Y. Endo, T. Mizuno, Y. Momoi, K. Ohno, T. Watari, H. Tsujimoto, and A. Hasegawa Molecular characterization of feline immunodeficiency virus genome obtained directly from organs of a naturally infected cat with marked neurological symptoms and encephalitis Arch. Virol. 141 10 1996 1933 1948
80. Y. Nishimura, T. Miyazawa, Y. Ikeda, Y. Izumiya, K. Nakamura, J.S. Cai, E. Sato, M. Kohmoto, and T. Mikami Molecular cloning and expression of feline CD3epsilon Vet. Immunol. Immunopathol. 65 1 1998 43 50
81. Y. Nishimura, T. Igarashi, O.K. Donau, A. Buckler-White, C. Buckler, B.A. Lafont, R.M. Goeken, S. Goldstein, V.M. Hirsch, and M.A. Martin Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses Proc. Natl. Acad. Sci. U.S.A. 101 33 2004 12324 12329
82. B.R. O'Keefe, S.R. Shenoy, D. Xie, W. Zhang, J.M. Muschik, M.J. Currens, I. Chaiken, and M.R. Boyd Analysis of the interaction between the HIV-inactivating protein cyanovirin-N and soluble forms of the envelope glycoproteins gp120 and gp41 Mol. Pharmacol. 58 5 2000 982 992
83. B.R. O'Keefe, D.F. Smee, J.A. Turpin, C.J. Saucedo, K.R. Gustafson, T. Mori, D. Blakeslee, R. Buckheit, and M.R. Boyd Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin Antimicrob. Agents Chemother. 47 8 2003 2518 2525
84. L.A. Obert, and E.A. Hoover Feline immunodeficiency virus clade C mucosal transmission and disease courses AIDS Res. Hum. Retroviruses 16 7 2000 677 688
85. R.A. Olmsted, V.M. Hirsch, R.H. Purcell, and P.R. Johnson Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses Proc. Natl. Acad. Sci. U.S.A. 86 20 1989 8088 8092
86. R.A. Olmsted, R. Langley, M.E. Roelke, R.M. Goeken, D. Adgerjohnson, J.P. Goff, J.P. Albert, C. Packer, M.K. Laurenson, T.M. Caro, L. Scheepers, D.E. Wildt, M. Bush, J.S. Martenson, and S.J. Obrien Worldwide prevalence of lentivirus infection in wild feline species-epidemiologic and phylogenetic aspects J. Virol. 66 10 1992 6008 6018
87. J. Overbaugh, P.A. Luciw, and E.A. Hoover Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections Aids 11 Suppl. A 1997 S47 S54
88. G. Pancino, I. Fossati, C. Chappey, S. Castelot, B. Hurtrel, A. Moraillon, D. Klatzmann, and P. Sonigo Structure and variations of feline immunodeficiency virus envelope glycoproteins Virology 192 2 1993 659 662
89. N.C. Pedersen, C.M. Leutenegger, J. Woo, and J. Higgins Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats Vet. Immunol. Immunopathol. 79 1-2 2001 53 67
90. S. Pohlmann, C. Davis, S. Meister, G.J. Leslie, C. Otto, J.D. Reeves, B.A. Puffer, A. Papkalla, M. Krumbiegel, A. Marzi, S. Lorenz, J. Munch, R.W. Doms, and F. Kirchhoff Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors J. Virol. 78 7 2004 3223 3232
91. S.L. Quackenbush, P.R. Donahue, G.A. Dean, M.H. Myles, C.D. Ackley, M.D. Cooper, J.I. Mullins, and E.A. Hoover Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS J. Virol. 64 11 1990 5465 5474
92. J. Richardson, G. Pancino, R. Merat, T. Leste-Lasserre, A. Moraillon, J. Schneider-Mergener, M. Alizon, P. Sonigo, and N. Heveker Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus J. Virol. 73 5 1999 3661 3671
93. G. Roderiquez, T. Oravecz, M. Yanagishita, D.C. Bou-Habib, H. Mostowski, and M.A. Norcross Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41 J. Virol. 69 4 1995 2233 2239
94. A.B. Rogers, and E.A. Hoover Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms J. Infect. Dis. 178 4 1998 960 967
95. A.B. Rogers, and E.A. Hoover Fetal feline immunodeficiency virus is prevalent and occult J. Infect. Dis. 186 7 2002 895 904
96. B. Rost, G. Yachdav, and J. Liu The predict protein server Nucleic Acids Res. 32 2004 W321 W326 (Web Server issue)
97. B. Schrofelbauer, D. Chen, and N.R. Landau A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif) Proc. Natl. Acad. Sci. U.S.A. 101 11 2004 3927 3932
98. M. Shimojima, Y. Nishimura, T. Miyazawa, K. Kato, Y. Tohya, and H. Akashi CD56 expression in feline lymphoid cells J. Vet. Med. Sci. 65 7 2003 769 773
99. M. Shimojima, T. Miyazawa, Y. Ikeda, E.L. McMonagle, H. Haining, H. Akashi, Y. Takeuchi, M.J. Hosie, and B.J. Willett Use of CD134 as a primary receptor by the feline immunodeficiency virus Science 303 5661 2004 1192 1195
100. K.H. Siebelink, J.A. Karlas, G.F. Rimmelzwaan, A.D. Osterhaus, and M.L. Bosch A determinant of feline immunodeficiency virus involved in Crandell feline kidney cell tropism Vet. Immunol. Immunopathol. 46 1-2 1995 61 69
101. D.L. Sodora, E.G. Shpaer, B.E. Kitchell, S.W. Dow, E.A. Hoover, and J.I. Mullins Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns J. Virol. 68 4 1994 2230 2238
102. R.F. Speck, K. Wehrly, E.J. Platt, R.E. Atchison, I.F. Charo, D. Kabat, B. Chesebro, and M.A. Goldsmith Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop J. Virol. 71 9 1997 7136 7139
103. A. Tanabe-Tochikura, T.S. Tochikura, J.R. Blakeslee Jr., R.G. Olsen, and L.E. Mathes Anti-human immunodeficiency virus (HIV) agents are also potent and selective inhibitors of feline immunodeficiency virus (FIV)-induced cytopathic effect: development of a new method for screening of anti-FIV substances in vitro Antivir. Res. 19 2 1992 161 172
104. J.A. Terwee, J.K. Yactor, K.S. Sondgeroth, and S. Vandewoude Puma lentivirus is controlled in domestic cats after mucosal exposure in the absence of conventional indicators of immunity J. Virol. 79 5 2005 2797 2806
105. J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, and D.G. Higgins The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools Nucleic Acids Res. 25 24 1997 4876 4882
106. F. Tozzini, D. Matteucci, P. Bandecchi, F. Baldinotti, K. Siebelink, A. Osterhaus, and M. Bendinelli Neutralizing antibodies in cats infected with feline immunodeficiency virus J. Clin. Microbiol. 31 6 1993 1626 1629
107. J.L. Troyer, J. Pecon-Slattery, M.E. Roelke, L. Black, C. Packer, and S.J. O'Brien Patterns of feline immunodeficiency virus multiple infection and genome divergence in a free-ranging population of African lions J. Virol. 78 7 2004 3777 3791
108. J.L. Troyer, J. Pecon-Slattery, M.E. Roelke, W.E. Johnson, S. VandeWoude, N. Vazquez-Salat, M. Brown, L. Frank, R. Woodroffe, C. Winterbach, H. Winterbach, G. Hemson, M. Bush, K.A. Alexander, and S.J. O'Brien Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus (FIV) among felidae and hyaenidae species J. Virol. 2005 (in revision)
109. C.C. Tsai, P. Emau, Y. Jiang, B. Tian, W.R. Morton, K.R. Gustafson, and M.R. Boyd Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques AIDS Res. Hum. Retroviruses 19 7 2003 535 541
110. C.C. Tsai, P. Emau, Y. Jiang, M.B. Agy, R.J. Shattock, A. Schmidt, W.R. Morton, K.R. Gustafson, and M.R. Boyd Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models AIDS Res. Hum. Retroviruses 20 1 2004 11 18
111. T. Uchiyama Human T cell leukemia virus type I (HTLV-I) and human diseases Annu. Rev. Immunol. 15 1997 15 37
112. T.W. Vahlenkamp, E.J. Verschoor, N.N. Schuurman, A.L. van Vliet, M.C. Horzinek, H.F. Egberink, and A. de Ronde A single amino acid substitution in the transmembrane envelope glycoprotein of feline immunodeficiency virus alters cellular tropism J. Virol. 71 9 1997 7132 7135
113. T.W. Vahlenkamp, M.B. Tompkins, and W.A. Tompkins Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells J. Immunol. 172 8 2004 4752 4761
114. S. VandeWoude, S.J. O'Brien, and E.A. Hoover Infectivity of lion and puma lentiviruses for domestic cats J. Gen. Virol. 78 Pt. 4 1997 795 800
115. S. VandeWoude, S.J. O'Brien, K. Langelier, W.D. Hardy, J.P. Slattery, E.E. Zuckerman, and E.A. Hoover Growth of lion and puma lentiviruses in domestic cat cells and comparisons with FIV Virology 233 1 1997 185 192
116. S. VandeWoude, C.L. Hageman, S.J. O'Brien, and E.A. Hoover Proceedings, 5th Intl. Feline Retrovirus Research Symposium, Cannes, France 2000
117. S. VandeWoude, C.A. Hageman, S.J. O'Brien, and E.A. Hoover Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus J. Acquir. Immune Defic. Syndr. 29 1 2002 1 10
118. S. VandeWoude, C.L. Hageman, and E.A. Hoover Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses J. Acquir. Immune Defic. Syndr. 34 1 2003 20 31
119. E.J. Verschoor, L.A. Boven, H. Blaak, A.L. van Vliet, M.C. Horzinek, and A. de Ronde A single mutation within the V3 envelope neutralization domain of feline immunodeficiency virus determines its tropism for CRFK cells J. Virol. 69 8 1995 4752 4757
120. D. Vodros, R. Thorstensson, G. Biberfeld, D. Schols, E. De Clercq, and E.M. Fenyo Coreceptor usage of sequential isolates from cynomolgus monkeys experimentally Infected with simian immunodeficiency virus (SIVsm) Virology 291 1 2001 12 21
121. D. Vodros, R. Thorstensson, R.W. Doms, E.M. Fenyo, and J.D. Reeves Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques Virology 316 1 2003 17 28
122. A.D. Weinberg, D.E. Evans, C. Thalhofer, T. Shi, and R.A. Prell The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement J. Leukocyte Biol. 75 6 2004 962 972
123. B.J. Willett, and M.J. Hosie The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus Mol. Membr. Biol. 16 1 1999 67 72
124. B. Willett, L. Picard, M. Hosie, J. Turner, K. Adema, and P. Clapham Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses J. Virol. 71 9 1997 6407 6415
125. B.J. Willett, J.N. Flynn, and M.J. Hosie FIV infection of the domestic cat: an animal model for AIDS Immunol. Today 18 4 1997 182 189
126. B.J. Willett, M.J. Hosie, J.C. Neil, J.D. Turner, and J.A. Hoxie Common mechanism of infection by lentiviruses Nature 385 6617 1997 587
127. B.J. Willett, K. Adema, N. Heveker, A. Brelot, L. Picard, M. Alizon, J.D. Turner, J.A. Hoxie, S. Peiper, J.C. Neil, and M.J. Hosie The second extracellular loop of CXCR4 determines its function as a receptor for feline immunodeficiency virus J. Virol. 72 8 1998 6475 6481
128. D.L. Willey, D.H. Smith, L.A. Lasky, T.S. Theodore, P.L. Earl, B. Moss, D.J. Capon, and M.A. Martin In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity J. Virol. 62 1988 139 147
129. Z. Yang PAML: a program package for phylogenetic analysis by maximum likelihood Comput. Appl. Biosci. 13 5 1997 555 556